Drugmakers Face $140 Bln Patent Loss: Report

The world's top drugmakers face the loss of $140 billion in annual sales by 2016 as key product patents expire and cheap generic versions of their blockbuster medicines hit the market, according to a report on Wednesday.
Yahoo Finance